Formulations containing hyaluronic acid
    8.
    发明授权
    Formulations containing hyaluronic acid 失效
    含有透明质酸的制剂

    公开(公告)号:US6114314A

    公开(公告)日:2000-09-05

    申请号:US352697

    申请日:1994-12-01

    IPC分类号: A61K31/70

    摘要: Topically applied transdermally quick penetrating (best targeting the epidermis and subsequently remaining there for a prolonged period of time) systemic independent acting, combinations and formulations which employ, combine, or incorporate a therapeutically effective non-toxic (to the patient) amount of a drug which inhibits prostaglandin synthesis together with an amount of hyaluronic acid and/or salts thereof (for example the sodium salt) and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub units of hyaluronic acid to treat a disease and condition of the skin and exposed tissue for example, basal cell carcinoma, the precancerous, often recurrent, actinic keratoses lesions, fungal lesions, "liver" spots and like lesions (found for the most part in the epidermis), squamous cell tumours, metastatic cancer of the breast to the skin, primary and metastatic melanoma in the skin, genital warts cervical cancer, and HPV (Human Papilloma Virus) including HPV of the cervix, psoriasis (both plaque-type psoriasis and nail bed psoriasis), corns on the feet and hair loss on the head of pregnant women and remain in the skin for a prolonged period of time.

    摘要翻译: 局部应用经皮快速穿透(最佳靶向表皮,随后长时间保留)系统性独立作用,组合和制剂,其使用,组合或并入治疗有效的无毒(至患者)量的药物 其与一定量的透明质酸和/或其盐(例如钠盐)和/或透明质酸的同系物,类似物,衍生物,复合物,酯,片段和/或亚单位一起抑制前列腺素合成以治疗疾病 皮肤和暴露组织的状况,例如基底细胞癌,癌前期,经常复发的光化性角化病变,真菌病变,“肝”斑点和类似病变(在大部分表皮中发现),鳞状细胞肿瘤, 乳腺对皮肤的转移性癌症,皮肤原发性和转移性黑素瘤,生殖器疣宫颈癌和HPV(人乳头状瘤病毒)包括HPV的HPV 子宫颈,牛皮癣(斑块型牛皮癣和指甲银屑病),脚上的玉米和孕妇头部的脱发,并长时间保持在皮肤中。

    Use of hyaluronic acid to repair ischemia reperfusion damage
    9.
    发明授权
    Use of hyaluronic acid to repair ischemia reperfusion damage 失效
    使用透明质酸修复缺血再灌注损伤

    公开(公告)号:US5674857A

    公开(公告)日:1997-10-07

    申请号:US200309

    申请日:1994-02-23

    IPC分类号: A61K31/728 A61K31/70

    CPC分类号: A61K31/728

    摘要: A pharmaceutical composition comprising an effective non-toxic amount of hyaluronic acid (HA) and or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and units of HA in association with a suitable diluent or pharmaceutically acceptable carrier for use in treating ischemia damage in tissue.

    摘要翻译: 包含有效无毒量的透明质酸(HA)及其盐和/或与适用的稀释剂或药学上可接受的载体结合使用的HA的同系物,类似物,衍生物,复合物,酯,片段和单元的有效无毒量的药物组合物 治疗组织缺血损伤。